Sanjeev Raghuwanshi

Hyderabad, TG 500046, India

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

FOXM1 induces therapy resistance and inhibits apoptosis in a variety of human cancers.

FOXM1 induces therapy resistance and inhibits apoptosis in a variety of human cancers.

Journal: Cell death & disease

Published: May 19, 2025

A novel FOXM1-BCL2A1 axis determines unfavorable response to venetoclax in AML.

A novel FOXM1-BCL2A1 axis determines unfavorable response to venetoclax in AML.

Journal: The Journal of biological chemistry

Published: November 18, 2024

Novel FOXM1 inhibitor STL001 sensitizes human cancers to a broad-spectrum of cancer therapies.

Novel FOXM1 inhibitor STL001 sensitizes human cancers to a broad-spectrum of cancer therapies.

Journal: Cell death discovery

Published: January 22, 2024

Small-molecule inhibitors targeting FOXM1: Current challenges and future perspectives in cancer treatments.

Small-molecule inhibitors targeting FOXM1: Current challenges and future perspectives in cancer treatments.

Journal: Biochimica et biophysica acta. Reviews on cancer

Published: August 26, 2023

Favorable outcomes of NPM1mut AML patients are due to transcriptional inactivation of FOXM1, presenting a new target to overcome chemoresistance.

Favorable outcomes of NPM1mut AML patients are due to transcriptional inactivation of FOXM1, presenting a new target to overcome chemoresistance.

Journal: Blood cancer journal

Published: June 03, 2023

Role of Long Non-Coding RNAs in Human-Induced Pluripotent Stem Cells Derived Megakaryocytes: A p53, HOX Antisense Intergenic RNA Myeloid 1, and miR-125b Interaction Study.

Role of Long Non-Coding RNAs in Human-Induced Pluripotent Stem Cells Derived Megakaryocytes: A p53, HOX Antisense Intergenic RNA Myeloid 1, and miR-125b Interaction Study.

Journal: The Journal of pharmacology and experimental therapeutics

Published: July 27, 2021

Endocannabinoid system: Role in blood cell development, neuroimmune interactions and associated disorders.

Endocannabinoid system: Role in blood cell development, neuroimmune interactions and associated disorders.

Journal: Journal of neuroimmunology

Published: October 26, 2020

Megakaryoblastic leukemia: a study on novel role of clinically significant long non-coding RNA signatures in megakaryocyte development during treatment with phorbol ester.

Megakaryoblastic leukemia: a study on novel role of clinically significant long non-coding RNA signatures in megakaryocyte development during treatment with phorbol ester.

Journal: Cancer immunology, immunotherapy : CII

Published: October 15, 2020

Co-stimulatory effect of TLR2 and TLR4 stimulation on megakaryocytic development is mediated through PI3K/NF-ĸB and XBP-1 loop.

Co-stimulatory effect of TLR2 and TLR4 stimulation on megakaryocytic development is mediated through PI3K/NF-ĸB and XBP-1 loop.

Journal: Cellular signalling

Published: September 07, 2020

Virodhamine, an endocannabinoid, induces megakaryocyte differentiation by regulating MAPK activity and function of mitochondria.

Virodhamine, an endocannabinoid, induces megakaryocyte differentiation by regulating MAPK activity and function of mitochondria.

Journal: Journal of cellular physiology

Published: February 20, 2020

RUNX1 and TGF-β signaling cross talk regulates Ca2+ ion channels expression and activity during megakaryocyte development.

RUNX1 and TGF-β signaling cross talk regulates Ca2+ ion channels expression and activity during megakaryocyte development.

Journal: The FEBS journal

Published: February 12, 2020

Exosome mediated differentiation of megakaryocytes: a study on TLR mediated effects.

Exosome mediated differentiation of megakaryocytes: a study on TLR mediated effects.

Journal: Journal of thrombosis and thrombolysis

Published: April 18, 2019

Showing 1-12 of 20

Last Updated: 09/26/2026